S100A9 and neoplasm: Based on the elevated S100A9 levels and its promotional role on carcinogenesis and metastasis, we next evaluated the correlation of serum S100A9 levels and clinical-pathological parameters such as tumor number, tumor diameter, TNM (tumor, node, metastasis) stage, extrahepatic metastasis status and HBV DNA load.